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Objectives: Recent authoritative studies suggested that low preoperative hemoglobin concentration may affect
cardiac surgery outcomes. This study aimed, primarily, to investigate whether preoperative anemia is an indepen-
dent determinant of adverse events after coronary artery bypass grafting and, secondarily, to evaluate the potential
dose responsiveness between anemia severity and primary end points.
Methods: This single-center prospective study investigated 1214 consecutive patients undergoing coronary ar-
tery bypass grafting between January 2004 and June 2007, collecting 100 variables per patient. In 1047 patients
(median age 64 years, 18.8% female, 38.9% diabetic, 31.9% urgent/emergency, 15.3% with low preoperative
left ventricular ejection fraction) who underwent on-pump procedures and received no preoperative transfusion,
the prevalence of preoperative anemia (according toWorld Health Organization definition) and its unadjusted and
adjusted relationships with in-hospital death, cardiac morbidity, and acute kidney injury (AKI–RIFLE [Risk, In-
jury, Failure, Loss, End-stage kidney disease] criteria) were obtained.
Results: The prevalence of preoperative anemia was 28%. In-hospital death averaged 3.9%, cardiac morbidity
7.3%, and acute kidney injury 4%. Unadjusted odds ratios (Ors) for in-hospital death, cardiac morbidity, and
acute kidney injury were 3.8 (95% confidence interval [CI] 2.0–7.3), 1.7 (95% CI 1.1–2.8), and 4.0 (95% CI
2.1–7.6), respectively. Adjusting for anemia in confounders proved an independent predictor of acute kidney in-
jury (OR 2.06; 95% CI 1.14–3.70), whereas the cardiac morbidity and in-hospital mortality were independently
predicted by kidney function. No dose–response relationship emerged between anemia severity and acute kidney
injury.
Conclusions: Preoperative anemia is independently associated with acute kidney injury after coronary artery
bypass grafting. Further studies are warranted to determine whether preoperative low hemoglobin concentration
is a marker of severity of illness or a modifiable risk factor.P
MDespite polarized positions on the benefits and risks of peri-
operative transfusions, uncertainty still exists over the im-
pact of preoperative anemia in patients undergoing cardiac
surgery.1,2 Indeed, this feature is increasingly encountered
in the already complex comorbid profile of the relentlessly
aging population referred for surgery. Data from recent au-
thoritative studies3-6 have disclosed preoperative hemoglo-
bin concentration as an independent risk factor for an
unfavorable outcome. Acute renal failure (ARF) and neuro-
logic injury, two of the most dreaded complications of car-
diac surgical procedures, were found to be statistically
linked to severe anemia. Furthermore, the causal relation
of different degrees of anemia severity to suboptimal out-
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odds for the development and validation of preventive man-
agement algorithms.
As part of our hospital’s ongoing continuous quality im-
provement program, we performed a prospective cohort
study designed to survey blood transfusion practice and its
effects on outcomes after cardiac surgical procedures. This
database was later used to determine the prevalence and
examine the implications of preoperative anemia in patients
referred for coronary artery bypass grafting (CABG) in
a tertiary care, university-affiliated center.
METHODS
Study Setting and Patient Sample
The studywas conducted at the Department of Cardiothoracic and Respi-
ratory Sciences of the Second University of Naples located in an affiliated
teaching hospital (V. Monaldi Hospital). At our institution, nearly 800
patients have cardiac surgery annually and are admitted to a dedicated
12-bed postoperative intensive care unit. Information from these patients
is collected on a daily basis using standardized case report forms; 100 peri-
operative data points (including demographics, laboratory tests, nature
of surgery, blood product transfusions, re-exploration, postoperative
complications, and lengths of stay in the intensive care unit and hospital)
are collected. Data are entered into a computerized database, which is
programmed to accept only matching double-entry data falling withinardiovascular Surgery c Volume 138, Number 4 965
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MAbbreviations and Acronyms
AKI ¼ acute kidney injury
ARF ¼ acute renal failure
CABG ¼ coronary artery bypass grafting
CKD ¼ chronic kidney disease
CPB ¼ cardiopulmonary bypass
GFR ¼ glomerular filtration rate
RIFLE ¼ Risk, Injury, Failure, Loss,
End-stage kidney disease
WHO ¼ World Health Organization
pre-specified ranges. All queries are resolved by referring to the patients’
original records. Of 1214 consecutive patients undergoing CABG between
January 2004 and June 2007, 1047 patients (median age 64 years, 18.8%
female, 38.9% diabetic, 31.9% urgent/emergency, 15.3% with low preop-
erative left ventricular ejection fraction) who underwent on-pump proce-
dures, received no preoperative transfusion, and were not receiving renal
replacement therapy constituted the study sample.
Surgical and Clinical Care
Details on surgical procedure and postoperative care have been reported
extensively elsewhere.7,8 Aprotinin was never used for bleeding prevention
because it is not authorized in our country; tranexamic acid was given pre-
operatively to patients on dual antiplatelet therapy. Heparinization wasman-
aged by both heparin blood level and activated coagulation time monitoring
throughout the operation. An intraoperative autologous blood salvage
method was used in every patient with preoperative anemia or dual antipla-
telet therapy. A specific perioperative transfusion algorithmwas applied: for
example, the patients received two units of packed red cells before cardio-
pulmonary bypass (CPB) whenever the preoperative hematocrit value was
below 30%, and they received two or more units of packed red cells during
CPB in case of excessive hemodilution (hematocrit value below 22%). Af-
ter CPB, the patients received packed red cells to maintain a hematocrit
value higher than 25%. This target value was raised to higher values accord-
ing to the clinical condition, and namely to the hemodynamic status, the
need for inotropic support, and the age of the patient. Fresh frozen plasma
was not used before reaching the intensive care unit. Platelets were usually
not transfused unless in patients reaching the operating room under full dose
of ticlopidine or clopidogrel and demonstrating severe postoperative bleed-
ing. Such protocol complies with current practice in other centers and
recently published guidelines.9,10
Study Design and Aims
An observational cohort design was used segregating study patients ac-
cording to the presence or absence of preoperative anemia. The prevalence
of preoperative anemia and its relationships with in-hospital death, cardiac
morbidity, and acute kidney injury (AKI) were obtained. Research protocol
was approved by the local ethics and research committee, which waived the
need for informed consent.
Baseline Data and Clinical Outcomes
All definitions were selected prospectively as part of the original study
design. The preoperative hemoglobin level was prospectively defined as
the lowest documented hemoglobin value among those measured at admis-
sion, during the preoperative period, or immediately before induction of an-
esthesia. Gender-based definition of anemia (12.0 g/dL in women and 13.0
g/dL in men) complied with statements by the World Health Organization
(WHO).11 The WHO grading scale for anemia severity was adopted.11
This scale categorizes anemia into five grades based on hemoglobin levels:966 The Journal of Thoracic and Cardiovascular Surgrade 0 (>11.0 g/dL); grade 1 (mild, 10.0–9.5 g/dL); grade 2 (moderate,
9.4–8.0 g/dL); grade 3 (serious/severe, 7.9–6.5 g/dL); and grade 4 (life-
threatening,<6.5 g/dL).
The change in kidney function was based on plasma creatinine concen-
tration and defined as the difference between baseline concentration and
the highest concentration during the stay in the intensive care unit. Preop-
erative glomerular filtration rate (GFR) and smallest GFR during intensive
care unit stay were calculated with the Modification of Diet in Renal Dis-
ease equation: estimated GFR ¼ 186 3 (plasma creatinine level [in mg/
dL]1.154 3 (age [in years])0.203. For women, the product of this equation
was multiplied by a correction factor of 0.742.12 To classify preoperative
kidney function, we adopted the National Kidney Foundation Classifica-
tion staging system.13 The severity of chronic kidney disease (CKD) is
described by six stages: the most severe three are defined by the Modifi-
cation of Diet in Renal Disease –estimated GFR value, and the first three
also depend on whether there is other evidence of kidney disease (eg,
proteinuria).
Stage 0. Normal kidney function: GFR above 90 mL $ min1 $ (1.73
m2)1 and no proteinuria
Stage 1. CKD1: GFR above 90 mL $ min1 $ (1.73 m2)1 with evidence
of kidney damage
Stage 2. CKD2 (mild): GFR of 60 to 89 mL $ min1 $ (1.73 m2)1 with
evidence of kidney damage
Stage 3. CKD3 (moderate): GFR of 30 to 59 mL $ min1 $ (1.73 m2)1
Stage 4. CKD4 (severe): GFR of 15 to 29 mL $ min1 $ (1.73 m2)1
Stage 5. CKD5 kidney failure (dialysis or kidney transplant needed):
GFR less than 15 mL $ min1 $ (1.73 m2)1
For postoperative AKI, the classification by the Acute Dialysis Quality
InitiativeWorkgroupwas referred to. This classification has been namedRI-
FLE according to the severity of renal impairment.14 The standard defines
three grades of severity—risk (class R), injury (class I) and failure (class
F)—and two outcome classes—loss of kidney function and end-stage kid-
ney disease. This classification system includes separate criteria for creati-
nine and urine output. A patient can fulfill the criteria through changes in
serum creatinine, GFR, or urine output: the criterion that leads to the worst
possible classification should be used. Class R is considered if there is an
increase of serum creatinine 3 1.5 or a GFR decrease greater than 25%
or a urinary output less than 0.5 mL $ kg1 $ h1 for 6 hours; class I is con-
sidered if there is an increase of serum creatinine 3 2 or a GFR decrease
greater than 50% or a urinary output less than 0.5 mL $ kg1 $ h1 for 12
hours; and class F is considered if there is an increase of serum creatinine
3 3 or a GFR decrease greater than 75%; in patients with a serum creatinine
greater than 4 mg/dL, if there is an acute rise in serum creatinine of at least
0.5 mg/dL or a urinary output less than 0.3 mL $ kg1 $ h1 for 24 hours or
anuria for 12 hours. The main parameters considered in this study for ARF
definition were creatinine and GFR, due to the heterogeneity of volemia sta-
tus and diuretic use in the study patients, affecting the relationship between
renal status and urine output.
Cardiac morbidity was defined as the occurrence of myocardial infarc-
tion and/or heart failure. The diagnosis of myocardial infarction required
the development of new Q waves, new persistent ST-segment or T-wave
changes associated with an elevation of creatinine kinase MB isoenzyme
values, or autopsy evidence of acute myocardial infarction. The diagnosis
of heart failure required either the use of an intra-aortic balloon pump or
ventricular assist device, the use of continuous inotropic support for at least
24 hours, or autopsy evidence of heart failure. Fatality (hospital mortality)
was defined as death occurring after surgery and during the index
hospitalization.
Statistical Analysis
Data are expressed as mean  SD for continuous variables and as per-
centages for categorical variables. Multivariable logistic regression model-
ing was carried out to assess the independent relationship between
preoperative anemia and the adverse outcomes. Initially, bivariate analysesgery c October 2009
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Baseline and surgical characteristics
Study population
(n ¼ 1047)
Anemia present
(n ¼ 320)
Anemia absent
(n ¼ 727) P value
Age (y) 63.2  9.3 66.9  8.9 61.5  9.1 <.0001
Body surface area (m2) 1.84  0.16 1.81  0.14 1.85  0.16 <.0001
Female sex (%) 18.8 25.3 16 .001
Diabetes mellitus (type I or II) (%) 38.9 39.4 38.7 .07
Hypertension (%) 70.1 70.9 69.7 .69
COPD (%) 13.7 13.5 13.1 .08
Peripheral vascular disease (%) 5.9 6.0 5.8 .52
Cerebrovascular disease (%) 6.9 7.1 6.6 .41
Hypercholesterolemia (%) 41.4 41.8 41.2 .67
Recent myocardial infarction (%) 29.9 35.6 29 .04
Left ventricular ejection fraction<35% (%) 15.3 20.3 13.1 .004
Baseline eGFR (mL $ min1 $ [1.73 m2]1) 64.2  31.6 60.2  49.56 66.2  18.7 <.0001
Preoperative medications (%)
Heparin within 24 h of surgery (%) 7.4 10 6.2 .019
Warfarin (within 5 d of surgery) 0.7 1.3 0.4 .2
Acetylsalicylic acid within 5 d of surgery (%) 45.2 45.3 45.1 1
Clopidogrel within 5 d of surgery (%) 14.2 15.4 13.7 .5
Angiotensin-converting enzyme inhibitor (%) 42.4 43.4 45.4 .58
COPD, Chronic obstructive pulmonary disease; eGFR, estimated glomerular filtration rate.P
M(using the c2 statistic for categorical variables and the t test or Wilcoxon
rank sum test for continuous variables) were carried out to identify preoper-
ative, intraoperative, and postoperative variables that were associated with
preoperative anemia, as defined above, and the adverse outcomes. Variables
that were not linearly related were mathematically transformed, categorized
along appropriate cut points, or converted into multiple dichotomous vari-
ables. All clinically sensible variables with values of P< .3 in bivariate
associations were entered into multivariable logistic regression models.
Subsequent retention in these models was determined with backward step-
wise selection, where P<.1 was the criterion for variable retention. Two of
these variables deserve special consideration: red blood cell transfusions
and preoperative anemia. Red blood cell transfusion is obviously a covariate
of low hemoglobin concentration at any stage during patient care, and the
preoperatively anemic patient in the present series had a 2-fold likelihood
to receive a transfusion in respect to the nonanemic counterpart. Many trig-
gers different from preoperative anemia may develop during the process of
care and determine transfusional need. A propensity score for the likelihood
to receive red blood cell transfusion was calculated to balance the effect of
preoperative anemia on the overall transfusional need throughout the pro-
cess of care.15 Prognostic factors available in the database were entered
into a bivariate analysis using as dependent variable a dummy dichotomous
variable reflecting the prevalence of transfused patients. Propensity scoring
was then derived by multivariable discriminant analysis by single step enter
method. The C statistic for such propensity model was 0.81. Propensity
score was forced to enter in the analysis for study end points as a linear
covariate (except for the cardiac morbidity model because of redundancy).The Journal of Thoracic and CPreoperative anemia was entered into the analysis both as a dichotomous
variable (absence or presence) and also as a multimodal categorical variable
according to the prespecified anemia severity scoring. All statistical analy-
ses were performed with SPSS 10.0 (SPSS Inc, Chicago, Ill).
RESULTS
Study Population
Prevalence of preoperative anemia was 28%. Anemia
severity according to WHO scaling system was: 0 (none)
71.9%, 1 (mild) 20%, 2 (moderate) 7.8%, and 3 (severe)
0.3%. Table 1 summarizes demographic characteristics along
withmedicalhistory andpreoperativemedications.Anemicpa-
tients proved to have a significantlymore complex comorbidity
profile. Table 2 displays main surgical characteristics. Anemic
patients had a significantly higher surgical priority status. No
difference emerged as to other features of surgical procedure.
Perioperative Hemoglobin Levels and Transfusion
Practice
Details on hemoglobin levels and transfusion require-
ments during the perioperative period are reported in Table 3.
Nearly 45.9% of the study population received a transfusionTABLE 2. Surgical characteristics
Surgical characteristics Study population (n ¼ 1047) Anemia present (n ¼ 320) Anemia absent (n ¼ 727) P value
Emergent surgery (%) 7.4 10 6.2 .019
Urgent surgery (%) 24.5 27.5 23.2 .019
Redo surgery (%) 1.0 1.3 0.8 .5
Distal anastomosis, No. 2.66  0.84 2.67  0.83 2.66  0.85 .78
CPB duration (min) 83.9  33.2 85.3  35.5 83.2  32.2 .348
Aortic crossclamp duration (min) 44.9  20.2 45.2  20.4 44.8  20.1 .799
Indexed CPB flow (L $ min1 $ m2) 2.37  0.2 2.39  0.12 2.36  0.23 .06
CPB, Cardiopulmonary bypass.ardiovascular Surgery c Volume 138, Number 4 967
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Perioperative Hb/Hct and transfusion variables Study population (n ¼ 1047) Anemia present (n ¼ 320) Anemia absent (n ¼ 727) P value
Hb, preoperative (g/dL) 13.42  1.69 11.49  1.15 14.27  1.08 <.0001
RBCs during CPB (mean  SD) 0.55  1.06 1.25  1.41 0.25  0.67 <.0001
Hct, lowest during CPB (%) 27.3  3.9 25.4  3.2 28.1  3.9 <.0001
DO2, lowest during CPB (mL $ min
1 $ m2) 297.6  48.9 279.8  38 305.5  51.1 <.0001
RBCs in OR (mean  SD) 0.8  1.54 1.66  1.88 0.43  1.04 <.0001
Hb, ICU admission (g/dL) 9.33  1.16 8.8  0.9 9.5  1.1 <.0001
Chest drains (mL/24 h) 702.6  356.6 702.6  356.6 727.9  365.8 .3
Resternotomy for bleeding (%) 2.4 2.5 2.3 .514
RBCs in ICU 1.07  1.92 1.50  2.27 0.88  1.71 <.0001
Overall RBC transfusion (mean  SD) 2.05  2.89 3.39  3.52 1.46  2.34 <.0001
Overall PLT transfusion 1.60  3.97 1.95  5.11 1.45  3.32 <.0001
Overall FFP transfusion 1.54  3.22 1.96  3.67 1.36  2.98 .006
Transfused patients (%) 45.9 71.6 34.7 <.0001
Hb,Hemoglobin;Hct, hematocrit; RBC, red blood cell;CPB, cardiopulmonary bypass; SD, standard deviation;DO2, oxygen delivery;OR, operating room; ICU, intensive care unit;
PLT, platelet; FFP, fresh frozen plasma.during the hospitalization. Anemic patients received signif-
icantly more red blood cells, fresh frozen plasma, and plate-
let transfusions during each step of the process of care but
never reached hemoglobin levels comparable with those reg-
istered in the nonanemic subset.
Study End Points
Anemic patients had significantly worse outcomes in
terms of both primary end point and overall hospital morbid-
ity as depicted in Table 4. National Kidney Foundation grad-
ing of preoperative estimated GFR was significantly higher
in the anemic subgroup; both study samples had a significant
worsening of renal function after the surgical procedure.
Incidence of AKI according to RIFLE scoring was signifi-
cantly higher in the anemic subgroup (Normal 59.4%,
Risk 31.2%, Injury 7.5%, and Failure 1.9% versus Normal
60%, Risk 33.3%, Injury 3.4%, and Failure 0.3%
(Figure 1). Hospital mortality rates in RIFLE classes for
the anemic subset were as follows: Normal 2.6%, Risk
7%, Injury 37.5%, and Failure 66.7%. Fatality rate for
the nonanemic counterpart were as follows: Normal 0.9%,
Risk 2.5%, Injury 20%, and Failure 50%.
Multivariable logistic regression analysis for primary end
points is reported in Table 5. Age, baseline kidney function
(estimated GFR), RIFLE scoring, and propensity scoring for
transfusion proved independent predictors of hospital mor-
tality. Preoperative anemia emerged as an independent pre-
dictor of AKI along with insulin-dependent diabetes mellitus
and propensity score for transfusion. No dose–response rela-
tionship between anemia severity and AKI emerged. Recent
myocardial infarction, peak postoperative renal function
(estimated GFR), need for transfusions, and CPB length in-
dependently predicted cardiac complications.
DISCUSSION
This prospective observational single-center study of an
unselected consecutive series of on-pumpCABGprocedures968 The Journal of Thoracic and Cardiovascular Sufound that preoperative anemia was a highly prevalent
feature that independently predicted AKI. Prevalence of ane-
mia and complexity of preoperative comorbid profile of the
patient subset are homogeneous to that disclosed in available
series of patients undergoing cardiac surgery.3-6 ARF after
cardiac surgery, depending on the specific definition, occurs
in up to 30% of all patients and anemia is nearly the second
cause of ARF in the intensive care unit.16
Until recently, there has been no consensus as to diagnostic
criteria or clinical definition of ARF. The RIFLE criteria were
developed to standardize the diagnosis ofARF and, in the pro-
cess, the term acute kidney injury (AKI) has been proposed to
encompass the entire spectrum of the syndrome from minor
changes in renal function to requirement for renal replacement
therapy.14 Thus, AKI is not just ARF but a more general de-
scription. Indeed, small changes in kidney function in patients
having cardiac surgery are important and significantly affect
short- and possibly long-term outcomes.17 The RIFLE criteria
provide a uniform definition of AKI and have now been vali-
dated in numerous studies in the cardiac surgery setting.18,19
Data from the present study are consistent with published se-
ries demonstrating that costs, lengths of hospital stay, and
mortality are higher in patients in whom AKI develops after
cardiac surgery according to RIFLE criteria, and these values
increase as AKI severity worsens.
AKI pathogenesis is complex and multifactorial. It likely
involves at least six major injury pathways: exogenous and
endogenous toxins, metabolic factors, ischemia and reperfu-
sion, neurohormonal activation, inflammation, and oxida-
tive stress. These mechanisms of injury are likely to be
active at different times with different intensity and probably
act synergistically.16
Recently, major studies found preoperative anemia to be an
independent predictor of AKI.3-6 Both studies were unable to
define the specific pathogenetic pathway but stressed the role
of reduced oxygen delivery and the harms of transfusions,
known predictors of postoperative kidney dysfunction.20rgery c October 2009
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Outcomes Study population (n ¼ 1047) Anemia present (n ¼ 320) Anemia absent (n ¼ 727) P value
Cardiac complications (%) 7.3 10.3 5.9 .014
Peak eGFR (mL $ min1 $ [1.73 m2]1) 64.2  31.6 60.2  49.56 66.2  18.7 <.0001
CVVH (%) 3.4 6.4 2.2 .002
Prolonged ventilation (>24 h) (%) 3.2 5.3 2.3 .021
Stroke (%) 1.9 2.8 1.5 .22
Deep sternal wound infection (%) 1.5 1.5 1.6 1.0
ICU stay (d) 3.2  3.9 3.9  5.2 2.9  3.2 <.0001
Hospital stay (d) 8.07  4.7 8.9  5.8 7.6  4.1 <.0001
Hospital death (%) 3.9 7.8 2.2 <.0001
eGFR, Estimated glomerular filtration rate; CVVH, continuous venovenous hemofiltration; ICU, intensive care unit.P
MPathogenesis of target events is well beyond the aims and pos-
sibilities of the present series; nevertheless, it is important to
notice that anemic patients had a significantly lower oxygen
delivery along with lower nadir hematocrit value on CPB,
and they had lower hemoglobin levels throughout the entire
process of care combined with significantly higher cardiac
morbidity and transfusions requirements. In this respect, it is
noteworthy that the propensity score for the likelihood to re-
ceive transfusion appeared as another independent predictor
of AKI. First, it powerfully reinforces the role of preoperative
anemia. Second, such findings closely mirror results of large
authoritative reports on drawbacks of red blood cell transfu-
sion on cardiac surgery outcomes.20
As to secondary end points, the lack of a dose–response
relationship between preoperative anemia and AKI, in the
context of at most moderate severity, further enhances the
importance of this feature, arguing in favor of a low thresh-
old attention toward the problem of preoperative any-degree
anemia in patients scheduled for CABG. Although the mark-
edly skewed distribution of patients within the three groups
of different anemia WHO grades may have negatively af-
fected the statistical power of the analysis of dose–response
relationship between anemia and AKI, such patient popula-
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70%
Normal Risk Injury Failure
Non Anemic Anemic
p<0.0001
AKI - RIFLE Scoring
FIGURE 1. RIFLE scoring in the anemic and nonanemic subsets. AKI,
Acute kidney injury; RIFLE, Risk, Injury, Failure, Loss, End-stage kidney
disease.The Journal of Thoracic and Ction composition reflects the ‘‘real-world’’ scenario and is
similar to those reported in previous studies.3-6
Final considerations deserve the results of multivariable
analysis for cardiacmorbidity predictors. Beside known deter-
minants (recent myocardial infarction andCPB time), transfu-
sions statistically emerged. This finding is homogeneous with
data forwarded by Surgenor and coworkers.21 In that study,
exposure to both hemodilutional anemia and red blood cell
transfusion during surgery were indeed associated with in-
creased risk of low-output heart failure after CABG.
Study Overview
Several study limitations should be considered for
a thorough data interpretation. First, the single-center set-
ting, although guaranteeing a uniform process of care with
special emphasis on transfusion triggers, closely reflects
the influence of specific standards of clinical practice and
a unique patient population that may have led to one-sided
results not readily transferable to other patient populations.
On the other side, correctness of statistical tools in balancing
for confounders makes results of this analysis, of an
TABLE 5. Independent risk factors for primary end points
Primary end points
and risk factors b OR 95% CI P value
Hospital mortality
Age 0.056 1.06 1.002–1.116 .041
Baseline eGFR 0.024 0.98 0.96–0.99 .006
RIFLE 2.53 12.53 5.29–29.7 <.001
Propensity score 0.87 2.4 1.65–3.43 <.001
Acute kidney injury
Preoperative anemia 0.72 2.06 1.14–3.70 .016
IDDM 1.03 2.8 1.20–6.50 .017
Propensity score 0.80 2.23 1.80–2.80 <.001
Cardiac morbidity
Recent myocardial
infarction
0.7 2.07 1.02–4.20 .043
Transfusion 1.15 3.16 1.73–5.80 <.001
Peak eGFR 0.02 0.98 0.971–0.994 .002
CPB duration 0.007 1.007 1.001–1.013 .026
OR, Odds ratio; CI, confidence intervals; eGFR, estimated glomerular filtration rate;
RIFLE, Risk, Injury, Failure, Loss, End-stage kidney disease; IDDM, insulin-depen-
dent diabetes mellitus; CPB, cardiopulmonary bypass.ardiovascular Surgery c Volume 138, Number 4 969
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Munselected consecutive series of patients experiencing al-
most all clinically relevant events, transferable.
Second, oxygen delivery was determined only during
CPB. The finding that hemoglobin concentrations at study
time points were markedly lower in the anemic subset than
in the nonanemic counterpart, in the absence of data on tis-
sue oxygen supply, substantially prevents an unbiased defi-
nition of the mechanisms by which preoperative anemia led
to increased morbidity and mortality.
Third, given the observational nature of our study, we can-
not determine the causal relationship between anemia and risk
of postoperative adverse events; neither can we relate the
etiology and chronicity of the illness with outcomes. This is
particularly important when considering the treatment of ab-
normal hemoglobin values. If these changes are reflective of
underlying conditions, then severity of preoperative anemia
may be a marker of risk and not a modifiable risk factor.
CONCLUSIONS
This single-center prospective observational study found
that preoperative anemia is an independent predictor of
AKI, a major determinant of hospital mortality after
CABG. Further studies are warranted to determine whether
preoperative low hemoglobin concentration is a marker of
severity of illness or a modifiable risk factor.
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